M A Demidova Selected Research

moexipril (Perdix)

1/2006	[Comparative efficacy and safety of contemporary Angiotensin converting enzyme inhibitors moexipril and spirapril in women with postmenopausal metabolic syndrome].
1/2006	[Hypotensive, organoprotective, and metabolic effects of Angiotensin converting enzyme inhibitor moexipril in women with postmenopausal syndrome].
1/2005	[Moexipril influence on quality of life in postmenopausal women with arterial hypertension].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M A Demidova Research Topics

Disease

3	Hypertension (High Blood Pressure) 01/2006 - 01/2005
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2006 - 01/2006
1	Hyperinsulinism (Hyperinsulinemia) 01/2006
1	Obesity 01/2006
1	Adenocarcinoma 01/2001

Drug/Important Bio-Agent (IBA)

3	moexipril (Perdix)FDA LinkGeneric 01/2006 - 01/2005
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2006 - 01/2005
2	CholesterolIBA 01/2006 - 01/2006
2	Triglycerides (Triacylglycerol)IBA 01/2006 - 01/2006
1	AlbuminsIBA 01/2006
1	CarbohydratesIBA 01/2006
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2006
1	spirapril FDA Link 01/2006
1	LDL CholesterolIBA 01/2006
1	LeptinIBA 01/2006
1	LipidsIBA 01/2006
1	Lipoproteins (Lipoprotein)IBA 01/2006
1	Immunologic Factors (Immunomodulators)IBA 01/2001
1	glikopinIBA 01/2001